COVID-19 Vaccine Tied to Increased Survival in Cancer Patients
Administration of a COVID-19 vaccine within 100 days of immune checkpoint inhibitors (ICIs) initiation is associated with increased overall survival in cancer patients.
A study presented at the European Society for Medical Oncology annual meeting found this correlation in patients with advanced lung or skin cancer.
For patients with certain types of advanced lung or skin cancer, administration of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) mRNA vaccine within 100 days of starting ICIs is associated with increased overall survival.
- Researchers from the University of Texas MD Anderson Cancer Center extracted data for patients with non-small cell lung cancer (NSCLC) and melanoma treated with ICIs.
- The study aimed to examine whether mRNA vaccines targeting nontumor antigens would sensitize tumors to ICIs.
Author's summary: COVID-19 vaccine increases survival in cancer patients.
More News
- Lightning vs. Islanders Prediction, Odds, Picks - Dec. 6
- JUST IN: Kelly Olynyk has been waived by the San Antonio Spurs
- NBA: Spurs at Timberwolves
- Lando Norris wins his first F1 title despite Max Verstappen victory: Live updates and reaction
- Guadeloupean artist Kelly Sinnapah Mary wins French art prize at Art Basel Miami Beach
- Game Preview: Islanders vs Lightning
- Kelly Osbourne — Instagram Snapshot
- Jack Osbourne breaks silence on jungle feud with Kelly Brook
- Tampa Bay Lightning vs. New York Islanders - Game Highlights
- Pelicans' Questionable Offseason Trade Looks Better After Saddiq Bey's Rise